Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Prognosis"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 678670

Starter badań:

Tytuł:
Multimodal prognostic models and recent therapeutic advances.
Autorzy:
Minervini A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy. Electronic address: .
Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
The Lancet. Digital health [Lancet Digit Health] 2023 Aug; Vol. 5 (8), pp. e482-e483. Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Prognosis*
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical predictive models in equine medicine: A systematic review.
Autorzy:
Cummings CO; Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Krucik DDR; Department of Comparative Medicine, Stanford University, California, USA.
Price E; Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Equine veterinary journal [Equine Vet J] 2023 Jul; Vol. 55 (4), pp. 573-583. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Prognosis*
Horses ; Animals ; Bias
Czasopismo naukowe
Szczegóły
Tytuł:
Pitfalls of the concordance index for survival outcomes.
Autorzy:
Hartman N; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Kim S; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Republic of Korea.
He K; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Kalbfleisch JD; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2023 Jun 15; Vol. 42 (13), pp. 2179-2190. Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Prognosis*
Humans ; Probability ; Survival Analysis
Czasopismo naukowe
Szczegóły
Tytuł:
CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models.
Autorzy:
Fernandez-Felix BM; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain. .; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain. .
López-Alcalde J; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Institute for Complementary and Integrative Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland.; Faculty of Health Sciences, Universidad Francisco de Vitoria (UFV), Madrid, Spain.
Roqué M; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Iberoamerican Cochrane Centre - Sant Pau Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain.
Muriel A; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Nursing and Physiotherapy, Universidad de Alcala de Henares, Alcala de Henares, Spain.
Zamora J; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Institute of Metabolism and Systems Research, WHO Collaborating Centre for Global Women's Health, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Feb 17; Vol. 23 (1), pp. 44. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prognosis*
Humans ; Systematic Reviews as Topic ; Bias
Czasopismo naukowe
Szczegóły
Tytuł:
Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy.
Autorzy:
Wang F; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.; Department of Oncology, Zaozhuang Shizhong District People's Hospital, Zaozhuang, China.
Deng G; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Liang N; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Hu P; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Liu K; Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Liu T; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.
Li Y; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Yuan M; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong Provincial Qianfoshan Hospital, Weifang Medical University, Jinan, China.
Liu L; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.
Xie J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Qiao L; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Liu F; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Zhang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.; Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło:
Cancer biology & therapy [Cancer Biol Ther] 2023 Dec 31; Vol. 24 (1), pp. 2285367. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Humans ; Prognosis ; Biomarkers, Tumor/metabolism ; Immunotherapy/methods ; B7-H1 Antigen/metabolism ; Ferritins/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Influence of blood pressure variations during hemodialysis on the prognosis of dialysis patients.
Autorzy:
Ohta Y; Division of General Internal Medicine, Kyushu Dental University, Kitakyushu, Fukuoka, Japan.; Kokura Daiichi Hospital, Kitakyushu, Fukuoka, Japan.
Fukuhara M; Division of General Internal Medicine, Kyushu Dental University, Kitakyushu, Fukuoka, Japan.
Fujisawa R; Division of General Internal Medicine, Kyushu Dental University, Kitakyushu, Fukuoka, Japan.
Kanesaki M; Kokura Daiichi Hospital, Kitakyushu, Fukuoka, Japan.
Tsuruta H; Kokura Daiichi Hospital, Kitakyushu, Fukuoka, Japan.
Nakamura H; Kokura Daiichi Hospital, Kitakyushu, Fukuoka, Japan.
Kawano Y; Department of Medical Technology, Teikyo University Fukuoka, Omuta, Fukuoka, Japan.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2236336.
Typ publikacji:
Journal Article
MeSH Terms:
Hypotension*/epidemiology
Hypotension*/etiology
Kidney Failure, Chronic*/therapy
Humans ; Middle Aged ; Aged ; Aged, 80 and over ; Blood Pressure/physiology ; Dialysis ; Renal Dialysis/adverse effects ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer.
Autorzy:
Dong Y; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Zhang S; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Zhao S; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Xuan M; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Zhu G; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Zhang Z; State Key Laboratory of Oral Disease & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Guo W; Yunnan Key Laboratory of Stomatology, The Affiliated Hospital of Stomatology, School of Stomatology, Kunming Medical University, Kunming, Yunnan, PR China.
Pokaż więcej
Źródło:
Cancer biology & therapy [Cancer Biol Ther] 2023 Dec 31; Vol. 24 (1), pp. 2205342.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Tongue Neoplasms*/genetics
Tongue Neoplasms*/pathology
Humans ; Signal Transduction ; Lymphatic Metastasis ; Phosphatidylinositol 3-Kinases/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Prognosis ; rhoA GTP-Binding Protein/metabolism ; rac1 GTP-Binding Protein ; Chemokine CCL2/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma.
Autorzy:
Wang J; Department of Biliary-Pancreatic Surgery, The First People's Hospital of Foshan, Foshan, China.
Shi Y; Department of Medical Oncology, Beidahuang Industry Group General Hospital, Harbin, China.
Chen J; Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.; School of Medicine, Xiamen University, Xiamen, China.
Liu J; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Zhao X; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, China.
Pang J; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, China.
Sun X; Department of Hepatobiliary Surgery, The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, China.
Tian Y; Department of Hepatobiliary Surgery, The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, China.
Ou Q; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, China.
Xia F; Department of Hepatobiliary Surgery, The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, China.
Chen Y; Department of Hepatopancreatobiliary Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No. 2 Hospital), Ningbo, China.
Pokaż więcej
Źródło:
Cancer biology & therapy [Cancer Biol Ther] 2023 Dec 31; Vol. 24 (1), pp. 2223375.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholangiocarcinoma*/genetics
Cholangiocarcinoma*/therapy
Bile Duct Neoplasms*/genetics
Bile Duct Neoplasms*/therapy
Female ; Humans ; Proto-Oncogene Proteins p21(ras)/genetics ; Prognosis ; Bile Ducts, Intrahepatic/pathology ; Genomics ; Mutation
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of Cardiac and Cerebrovascular Complications During Hospitalization on Long-Term Prognosis in Patients With COVID-19.
Autorzy:
Tateishi K; Department of Cardiovascular Services, Englewood Hospital and Medical Center, Englewood, New Jersey. Electronic address: .
Hmoud H; Department of Cardiology, Lenox Hill Hospital Northwell Health, New York, New York.
De Gregorio L; Hackensack Meridian School of Medicine, Nutley, New Jersey.
De Gregorio I; Cooper Medical School of Rowan University, Camden, New Jersey.
Asselin CY; Department of Internal Medicine, Morristown Medical Center, Morristown, New Jersey.
De Gregorio J; Department of Cardiovascular Services, Englewood Hospital and Medical Center, Englewood, New Jersey.
Pokaż więcej
Źródło:
The American journal of cardiology [Am J Cardiol] 2023 Dec 15; Vol. 209, pp. 114-119. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
COVID-19*/complications
COVID-19*/epidemiology
Myocardial Infarction*
Stroke*/etiology
Humans ; Retrospective Studies ; Risk Factors ; Prognosis ; Hospitalization
Czasopismo naukowe
Szczegóły
Tytuł:
Stage 4N neuroblastoma before and during the era of anti-G D2 immunotherapy.
Autorzy:
Kushner BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
LaQuaglia MP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cardenas FI; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Basu EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Gerstle JT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kramer K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Roberts SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wolden SL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2023 Dec 15; Vol. 153 (12), pp. 2019-2031. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/therapy
Neoplasm Recurrence, Local*/pathology
Neuroblastoma*/genetics
Neuroblastoma*/therapy
Child ; Humans ; Infant ; Adolescent ; Prognosis ; N-Myc Proto-Oncogene Protein/genetics ; Neoplasm Staging ; Immunotherapy
Czasopismo naukowe
Szczegóły
Tytuł:
Identification of a Novel CD8  T cell exhaustion-related gene signature for predicting survival in hepatocellular carcinoma.
Autorzy:
Liu K; Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Liu J; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.; Department of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, 750002, China.
Zhang X; Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Liu D; Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Yao W; Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Bu Y; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China. .; Department of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, 750002, China. .
Chen B; Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, China. .; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 04; Vol. 23 (1), pp. 1185. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; T-Cell Exhaustion ; Genes, cdc ; Annexin A5 ; CD8-Positive T-Lymphocytes ; Prognosis ; Mad2 Proteins
Czasopismo naukowe
Szczegóły
Tytuł:
Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
Autorzy:
Liu W; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Xia K; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Zheng D; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Huang X; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Wei Z; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Wei Z; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province.
Guo W; Department of Orthopaedics, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China, Hubei Province. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 01; Vol. 23 (1), pp. 1179. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Osteosarcoma*/genetics
Bone Neoplasms*/genetics
Humans ; Animals ; Mice ; Prognosis ; Risk Factors ; Algorithms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors.
Autorzy:
Zhang R; Department of Operating Room, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150086, Heilongjiang, China.
Zhao H; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China.
Wang P; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China.
Guo Z; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China.
Liu C; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China.
Qu Z; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, Heilongjiang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 01; Vol. 23 (1), pp. 1181. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Prognosis ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 678670

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies